Perrigo (PRGO) Capital Expenditures (2013 - 2026)
Perrigo (PRGO) posted quarterly Capital Expenditures of $13.8 million for Q1 2026, down 45.88% year-over-year from $25.5 million in Q1 2025, and down 48.51% quarter-over-quarter from $26.8 million in Q4 2025.
Perrigo (PRGO) Capital Expenditures (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Capital Expenditures for 14 consecutive years, with $13.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 45.88% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $81.7 million (down 31.17% YoY), while the FY2025 annual figure was $93.4 million, down 21.05% from the prior year.
- Capital Expenditures declined to $13.8 million in Q1 2026 per PRGO's latest filing, from $26.8 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $86.1 million in Q4 2022 and bottomed at -$38.4 million in Q4 2022.
- Historically, Capital Expenditures has averaged $24.9 million across 5 years, with a median of $25.5 million in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 1845.45% — and 2023, when it soared 182.81%.
- Perrigo's Capital Expenditures stood at $86.1 million in 2022, then sank by 68.99% to $26.7 million in 2023, then soared by 41.2% to $37.7 million in 2024, then slipped by 28.91% to $26.8 million in 2025, then tumbled by 48.51% to $13.8 million in 2026.
- Business Quant data shows PRGO's Capital Expenditures at $13.8 million in Q1 2026, $26.8 million in Q4 2025, and $21.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.64 Bn | 39.99 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.26 Bn | 30.58 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.62 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.86 Bn | 17.98 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 14.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 14.30 Mn |
| Jun 27, 2026 | 14.30 Mn |
| Mar 28, 2026 | 13.80 Mn |
| Mar 28, 2026 | 13.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Sep 27, 2025 | 21.90 Mn |
| Sep 27, 2025 | 21.90 Mn |
| Jun 28, 2025 | 19.20 Mn |
| Jun 28, 2025 | 19.20 Mn |
| Mar 29, 2025 | 25.50 Mn |
| Mar 29, 2025 | 25.50 Mn |
| Dec 31, 2024 | 37.70 Mn |
| Dec 31, 2024 | 37.70 Mn |
| Sep 28, 2024 | 27.10 Mn |
| Sep 28, 2024 | 27.10 Mn |
| Jun 29, 2024 | 28.40 Mn |
| Jun 29, 2024 | 28.40 Mn |
| Mar 30, 2024 | 25.10 Mn |
| Mar 30, 2024 | 25.10 Mn |